Avanza Fonder AB Buys Shares of 187,780 Kenvue Inc. (NYSE:KVUE)

Avanza Fonder AB acquired a new position in shares of Kenvue Inc. (NYSE:KVUE - Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 187,780 shares of the company's stock, valued at approximately $4,009,000.

A number of other institutional investors also recently made changes to their positions in KVUE. Mutual of America Capital Management LLC grew its stake in shares of Kenvue by 40.4% in the second quarter. Mutual of America Capital Management LLC now owns 317,504 shares of the company's stock valued at $5,772,000 after acquiring an additional 91,398 shares in the last quarter. Meiji Yasuda Asset Management Co Ltd. increased its holdings in shares of Kenvue by 19.3% during the second quarter. Meiji Yasuda Asset Management Co Ltd. now owns 64,465 shares of the company's stock worth $1,172,000 after purchasing an additional 10,425 shares during the period. Amalgamated Bank raised its position in shares of Kenvue by 6.2% in the second quarter. Amalgamated Bank now owns 386,739 shares of the company's stock valued at $7,031,000 after buying an additional 22,605 shares in the last quarter. Elo Mutual Pension Insurance Co boosted its stake in shares of Kenvue by 13.0% in the second quarter. Elo Mutual Pension Insurance Co now owns 161,275 shares of the company's stock valued at $2,932,000 after buying an additional 18,498 shares during the period. Finally, XTX Topco Ltd acquired a new stake in Kenvue during the second quarter worth approximately $746,000. Institutional investors own 97.64% of the company's stock.

Wall Street Analyst Weigh In

Several brokerages have weighed in on KVUE. Deutsche Bank Aktiengesellschaft cut Kenvue from a "buy" rating to a "hold" rating and dropped their price objective for the company from $25.00 to $24.00 in a report on Thursday, December 12th. Barclays dropped their price target on Kenvue from $23.00 to $21.00 and set an "equal weight" rating for the company in a research note on Friday. Royal Bank of Canada upgraded shares of Kenvue from a "hold" rating to a "moderate buy" rating in a research note on Monday, December 9th. Piper Sandler upgraded shares of Kenvue from a "neutral" rating to an "overweight" rating and boosted their target price for the company from $21.00 to $26.00 in a research report on Monday, January 6th. Finally, Jefferies Financial Group initiated coverage on shares of Kenvue in a research report on Tuesday, September 24th. They set a "buy" rating and a $27.00 price target on the stock. One analyst has rated the stock with a sell rating, seven have given a hold rating and four have assigned a buy rating to the company's stock. According to MarketBeat.com, Kenvue has a consensus rating of "Hold" and an average target price of $23.08.

Kenvue Trading Down 0.4 %

Shares of NYSE:KVUE traded down $0.09 during midday trading on Friday, reaching $21.11. The company's stock had a trading volume of 11,266,973 shares, compared to its average volume of 8,612,558. Kenvue Inc. has a fifty-two week low of $17.67 and a fifty-two week high of $24.46. The company has a debt-to-equity ratio of 0.66, a quick ratio of 0.69 and a current ratio of 1.00. The firm has a 50 day moving average price of $22.42 and a two-hundred day moving average price of $21.66. The firm has a market capitalization of $40.46 billion, a price-to-earnings ratio of 38.37, a PEG ratio of 1.99 and a beta of 1.46.

Kenvue (NYSE:KVUE - Get Free Report) last issued its earnings results on Thursday, November 7th. The company reported $0.28 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.27 by $0.01. The business had revenue of $3.90 billion for the quarter, compared to analyst estimates of $3.92 billion. Kenvue had a net margin of 6.88% and a return on equity of 21.43%. Kenvue's revenue was down .4% on a year-over-year basis. During the same period in the prior year, the firm earned $0.31 earnings per share. As a group, analysts forecast that Kenvue Inc. will post 1.14 earnings per share for the current year.

Kenvue Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, February 26th. Shareholders of record on Wednesday, February 12th will be given a $0.205 dividend. The ex-dividend date of this dividend is Wednesday, February 12th. This represents a $0.82 annualized dividend and a yield of 3.89%. Kenvue's dividend payout ratio is currently 149.09%.

Kenvue Profile

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.